Hyperosmolar hyperglycemic state: Clinical sciences

3,425views

Hyperosmolar hyperglycemic state: Clinical sciences

2nd semester of 4th grade

2nd semester of 4th grade

Approach to anxiety disorders: Clinical sciences
Generalized anxiety disorder, agoraphobia, and panic disorder: Clinical sciences
Obsessive compulsive disorder (OCD): Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Specific phobia and social anxiety disorder (social phobia): Clinical sciences
Approach to joint pain and swelling: Clinical sciences
Gout: Clinical sciences
Osteoarthritis: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Approach to dyspnea: Clinical sciences
Asthma: Clinical sciences
Chronic obstructive pulmonary disease: Clinical sciences
Chronic kidney disease: Clinical sciences
Coronary artery disease: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Approach to mood disorders: Clinical sciences
Bipolar I, bipolar II, and cyclothymic disorder: Clinical sciences
Major depressive disorder and persistent depressive disorder (dysthymia): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Approach to lower limb edema: Clinical sciences
Congestive heart failure: Clinical sciences
Dyslipidemia: Clinical sciences
Approach to hypertension: Clinical sciences
Essential hypertension: Clinical sciences
Approach to involuntary movements: Clinical sciences
Approach to polyneuropathy: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Obesity (pediatrics): Clinical sciences
Osteoporosis: Clinical sciences
Sleep apnea: Clinical sciences
Substance use disorder: Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Opioid use disorder: Clinical sciences
Opioid withdrawal syndrome: Clinical sciences
Tobacco use: Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-patient care (GYN): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Non-accidental trauma and neglect (pediatrics): Clinical sciences
Approach to delay or regression in developmental milestones: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Emergency contraception: Clinical sciences
Reversible contraception: Clinical sciences
Immunizations (pediatrics): Clinical sciences
Well-patient care (adult): Clinical sciences
Well-patient care (geriatrics): Clinical sciences
Intimate partner violence and sexual assault: Clinical sciences
Breast cancer screening: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Cervical cancer screening: Clinical sciences
Colorectal cancer screening: Clinical sciences
Preconception care: Clinical sciences
Skin cancer screening: Clinical sciences
Sexually transmitted infection screening (Family medicine): Clinical sciences
Immunizations (adult): Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Hyperosmolar hyperglycemic state, or HHS for short, is a life-threatening complication of type 2 diabetes mellitus. It is usually triggered by a precipitating factor, such as illness or infection, that eventually leads to relative insulin deficiency, hyperglycemia, and elevated serum osmolality.

Keep in mind that there’s a higher risk of HHS in older individuals, especially those with impaired cognitive function or thirst perception, as well as those who do not adhere to their treatment regimen for diabetes. The diagnosis of HHS requires lab workup that demonstrates an elevated blood glucose and serum osmolality, as well as the absence of metabolic acidosis and ketonuria.

Now, if you suspect HHS, you should first perform an ABCDE assessment to determine if your patient is unstable or stable. HHS generally presents as unstable, so stabilize the airway, breathing, and circulation. Next, obtain IV access and give 1-liter bolus of isotonic IV fluid. Next, put your patient on continuous vital sign monitoring, including heart rate, blood pressure, and pulse oximetry, and provide supplemental oxygen, if needed.

Once you stabilize the patient, obtain a focused history and physical exam. Your patient typically reports polyuria, polydipsia, weakness, lethargy, or even seizures. These are commonly associated with a recent precipitating illness or infection. Additionally, there might be a known history of diabetes with inadequate glycemic control or recent disruption in therapy.

On the other hand, a physical exam might reveal signs of severe dehydration, such as dry mucous membranes, tachycardia, and hypotension. In severe cases, you might even notice somnolence and focal neurologic deficits, such as visual disturbance.

Based on these findings, suspect HHS and order labs, including an ABG or VBG, a serum osmolality, a CMP, and a urinalysis. Next, review the lab results and assess diagnostic criteria for HHS, which include blood glucose above 600 mg/dL; serum osmolality over 320 mOsm/kg; the absence of metabolic acidosis; and minimal or no ketonuria.

If diagnostic criteria for HHS are not met, you should consider alternative diagnoses. On the other hand, if the lab results show that HHS criteria are met, you can diagnose HHS and begin insulin treatment.

Here’s a clinical pearl! HHS can present with signs and symptoms that are similar to diabetic ketoacidosis, or DKA for short. Unlike HHS though, in DKA, the distinguishing feature is a ketoacidosis, with a pH under 7.3 and a serum bicarbonate below 15. Also, the serum glucose in DKA is usually less than 600 mg/dL. Another condition that may masquerade as HHS is diabetes insipidus. Individuals with diabetes insipidus can also present with extreme thirst, polyuria, lethargy, and increased serum osmolality, but unlike in HHS, hyperglycemia is not a feature of this condition.

Ok, now that we’ve diagnosed HHS, let’s turn our attention to management. Start with immediate IV fluid resuscitation, as well as a bolus of IV insulin, dosed at 0.1 unit per kilogram, followed by a constant IV insulin infusion at 0.1 units per kilogram per hour. At the same time, pay attention to the serum potassium level, because insulin and fluid resuscitation can lower serum potassium levels. If the serum potassium is above reference range, no potassium replacement is needed. On the other hand, if the serum potassium is below reference range or even within reference range, add potassium to the IV fluids. In fact, if the potassium is below the reference range, it's actually necessary to replace potassium before even starting insulin!

Here’s a high-yield fact to keep in mind! As soon as you give insulin, it will shift potassium from blood right into the cells, dangerously decreasing its blood levels. So a modestly low potassium of 3 could quickly reach a lethal level of 2.5 if you start the insulin drip before appropriately replacing the potassium.

Sources

  1. "American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update" Endocr Pract (2023)
  2. "Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State" Med Clin North Am (2017)
  3. "American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan" Endocr Pract (2011)
  4. "Harrison's: Principles of Internal Medicine, 20th edition" McGraw-Hill Education (2018)
  5. "Hyperglycemic crises in adult patients with diabetes" Diabetes Care (2009)